RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
0.790
-0.050 (-5.98%)
At close: Mar 6, 2026, 4:00 PM EST
0.820
+0.030 (3.76%)
After-hours: Mar 6, 2026, 7:10 PM EST
RenovoRx Market Cap
RenovoRx has a market cap or net worth of $28.96 million as of March 6, 2026. Its market cap has decreased by -20.94% in one year.
Market Cap
28.96M
Enterprise Value
19.15M
1-Year Change
-20.94%
Ranking
Category
Stock Price
$0.79
Market Cap Chart
Since the IPO on August 26, 2021, RenovoRx's market cap has decreased from $68.64M to $28.96M, a decrease of -57.81%. That is a compound annual growth rate of -17.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 28.96M | -5.94% |
| Dec 31, 2025 | 30.79M | -0.56% |
| Dec 31, 2024 | 30.96M | 26.43% |
| Dec 29, 2023 | 24.49M | 14.54% |
| Dec 30, 2022 | 21.38M | -50.41% |
| Dec 31, 2021 | 43.12M | -37.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tempest Therapeutics | 31.14M |
| Werewolf Therapeutics | 30.67M |
| Lantern Pharma | 30.20M |
| Tevogen Bio Holdings | 29.59M |
| FibroBiologics | 29.40M |
| NeuroSense Therapeutics | 28.92M |
| Dyadic International | 27.78M |
| Kyntra Bio | 27.67M |